Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 43 - Drugs for specific purposes, not provided for in groups
Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317)
08/2005
08/18/2005CA2555024A1 Use of factor viia for treating late complications of trauma
08/18/2005CA2552285A1 Sulfhydryl protected glythathione prodrug
08/17/2005EP1564236A1 Modified biological substance, process for producing the same, and intermediate
08/17/2005EP1564213A1 Imidazole derivative, process for producing the same, and use
08/17/2005EP1564210A1 4-oxoquinoline compounds and utilization thereof as hiv integrase inhibitors
08/17/2005EP1563847A1 Agent eleveting dendritic cell precursor level in blood
08/17/2005EP1563845A1 Remedies for allergic diseases
08/17/2005EP1563843A1 Botulinum toxins for treating various disorders and associated pain
08/17/2005EP1563841A1 Remedies
08/17/2005EP1563839A1 A method of analgesia
08/17/2005EP1563836A1 Drug for inhibiting production of matrix metalloprotease-9
08/17/2005EP1563059A1 Methods, nucleic acid constructs and cells for treating neurodegenerative disorders
08/17/2005EP1562937A2 N-substituted piperidine derivatives as serotonin receptor agents
08/17/2005EP1562933A2 Substituted amine derivatives and methods of use in the treatment of angiogenesis related disorders
08/17/2005EP1562579A1 Therapeutic delivery of carbon monoxide
08/17/2005EP1562578A1 Therapeutic delivery of carbon monoxide to extracorporeal and isolated organs
08/17/2005EP1562572A2 Pharmaceutical solutions of modafinil compounds
08/17/2005EP1499594B1 Process for the preparation of 7-substituted-3-quinoline and 3-quinol-4-one carbonitriles
08/17/2005EP1496889B1 Stabilized ascorbic acid derivatives
08/17/2005EP1463725B1 Process and intermediates for pyridazinone antidiabetic agents
08/17/2005EP1461445A4 Glycoprotein remodeling using endoglycanases
08/17/2005EP1429617A4 Methods for sterilizing preparations of digestive enzymes
08/17/2005EP1427830A4 Bv8 NUCLEIC ACIDS AND POLYPEPTIDES WITH MITOGENIC ACTIVITY
08/17/2005EP1377558B1 [1,4]-diazepane-1-carboxylic acid derivatives, process for their preparation and their use as tachykinin antagonists
08/17/2005EP1354597B1 Pharmaceutical combination for the treatment of tissue damage owing to an arterial irrigation defect
08/17/2005EP1316558B1 Tetraphenylbacteriochlorin derivatives and compositions containing the same
08/17/2005EP1282639B1 Polyamide nucleic acid derivatives, agents and methods for producing the same
08/17/2005EP1282418B1 Use of pyrazole derivatives for treating infertility
08/17/2005EP1280757B1 New gamma selective retinoids
08/17/2005EP1248651B1 Product comprising a heterotrimeric g protein signal transduction inhibitor associated with anti-hypertensive agent for therapeutic use in the treatment of arterial hypertension
08/17/2005EP1248643B1 The use of copolymer 1 and related peptides and polypeptides and t cells treated therewith for neuroprotective therapy
08/17/2005EP1225913B1 Use of nitric oxide for the treatment of airway constriction
08/17/2005EP1196397B1 Metabotropic glutamate receptor antagonists and their use for treating central nervous system diseases
08/17/2005EP1192164B1 Thieno- and furopyrimidine derivatives as a2a-receptor antagonists
08/17/2005EP1181274A4 Iminocyclitol inhibitors of hexoaminidase and glycosidase
08/17/2005EP1173178B1 Composition comprising apomorphine and sildenafil and the use thereof for the treatment of erectile dysfunction
08/17/2005EP1144385B1 Benzoheterocycles and their use as mek inhibitors
08/17/2005EP1100878B8 Process for producing genetically modified cd34-negative adherently growing haematopoietic stem cells
08/17/2005EP1087943B1 Therapeutic biaryl derivatives
08/17/2005EP1087775B1 Preventing cerebral infarction through administration of adp-receptor antiplatelet and antihypertensive drugs in combination
08/17/2005EP1023067B9 The use of inhibitors of the renin-angiotensin system for the treatment of hypoxia or impaired metabolic function
08/17/2005EP0989982B1 Barbituric acid derivatives with antimetastatic and antitumor activity
08/17/2005EP0984983B1 Modulators of intracellular inflammation, cell death and cell survival pathways containing a card and a kinase domain
08/17/2005EP0975674B1 Immunotoxins, comprising an onc protein, directed against malignant cells
08/17/2005EP0894085B1 Benzyl(idene)-lactam derivatives, their preparation and their use as selective (ant)agonists of 5-ht1a- and/or 5-ht1d receptors
08/17/2005EP0835128B1 Use of il-11 to treat inflammation
08/17/2005EP0732930B1 Compositions which inhibit apoptosis, methods of purifying the compositions and uses thereof
08/17/2005CN1656237A Antiviral inhibition of capsid proteins
08/17/2005CN1656122A Human monoclonal antibodies to interleukin-5 and methods and compositions comprising same
08/17/2005CN1656114A Novel pancortin-pablo protein interactions and methods of use thereof
08/17/2005CN1656113A Sialic combined immunoglobulin like agglutinin inhibitors
08/17/2005CN1656109A Non nucleoside reverse transcriptase inhibitors
08/17/2005CN1656102A Fused bicyclic pyridine derivative as tachykinin receptor antagonist
08/17/2005CN1656101A Esters in position 20 of camptothecins
08/17/2005CN1656100A Camptothecins with a modified lactone ring
08/17/2005CN1656098A Fused bicyclic pyrimidine derivatives
08/17/2005CN1656096A Alkyl-substituted imidazopyridines for the treatment of gastrointestinal disorders
08/17/2005CN1656095A Spiro derivatives and adhesion molecule inhibitors comprising the same as the active ingredient
08/17/2005CN1656094A 7-azaindoles as inhibitors of c-Jun N-terminal kinases for the treatment of neurodegenerative disorders
08/17/2005CN1656093A 3-substituted quinuclidines and their use
08/17/2005CN1656092A Robertson Graeme Michael et al.
08/17/2005CN1656091A Tetrahydropyran derivatives
08/17/2005CN1656090A Heterocyclic compounds which inhibit leukocyte adhesion mediated by alpha4 integrins
08/17/2005CN1656089A Phenyl-thiophene type vitamin D receptor modulators
08/17/2005CN1656088A Substituted chroman derivatives having cytochrome P450RAI inhibitory activity
08/17/2005CN1656085A Carboxylic acid compounds and drugs containing the compounds as the active ingredient
08/17/2005CN1656084A Hydroxymorpholinone derivative and medicinal use thereof
08/17/2005CN1656082A Protein kinase inhibitors
08/17/2005CN1656081A 4-anilino quinazoline derivatives as antiproliferative agents
08/17/2005CN1656079A Pyrazole compounds and pharmaceutical compositions comprising the compound
08/17/2005CN1656077A Process for preparing chiral diol sulfones and dihydroxy acid HMG CoA reductase inhibitors
08/17/2005CN1656075A Quinoline derivatives and their use as 5-HT6 ligands
08/17/2005CN1656073A Diaryl urea derivatives useful for the treatment of protein kinase dependent diseases
08/17/2005CN1656072A Phenyl heterocyclyl ether derivatives as serotonin re-uptake inhibitors
08/17/2005CN1656067A New salts
08/17/2005CN1656058A Amide derivatives as inhibitors of the enzymatic activity of renin
08/17/2005CN1656057A N-acylaminobenzene dervatives as selective monoamine oxidase b inhibitors
08/17/2005CN1655826A Non-viral gene delivery system
08/17/2005CN1655823A Topically applicable pharmaceutical preparation
08/17/2005CN1655820A Pharmaceutical combination of PDE5 inhibitors with ace inhibitors
08/17/2005CN1655816A Drugs for treating vascular diseases
08/17/2005CN1655814A Antibody selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor and uses thereof
08/17/2005CN1655813A Parakeratosis inhibitor, pore-shrinking agent and skin preparation for external use
08/17/2005CN1655812A Anitmicrobial polymer conjugates
08/17/2005CN1655803A Methods of improving central nervous system functioning
08/17/2005CN1655799A Antiinflammatory agent, agent for preventing/ameliorating allergic diseases and functional food
08/17/2005CN1655792A Combination product of a 1, 4-benzothiepine 1, 1-dioxide compound with at least one other active ingredient and the use of the product
08/17/2005CN1655790A Medicinal composition
08/17/2005CN1655789A New pharmaceutical compositions containing flibanserin polymorph A
08/17/2005CN1655788A 1H-imidazo[4, 5-c]quinoline derivatives in the treatment of protein kinase dependent diseases
08/17/2005CN1655787A Triple monoamine reuptake inhibitors for the treatment of chronic pain
08/17/2005CN1655785A N-acyl piperidine derivatives for use as melanocortin receptor ligands in the treatment of feeding disorders
08/17/2005CN1655784A Use of compounds that are effective as selective opiate receptor modulators
08/17/2005CN1655783A Phosphodiesterase iv inhibitor containing pyridylacrylamide derivative
08/17/2005CN1655782A Ophthalmological use of roflumilast for the treatment of diseases of the eye
08/17/2005CN1655781A Novel heterocyclic compounds which are active as inhibitors of beta-lactamases
08/17/2005CN1655780A Thiazolidine carboxamide derivatives as modulators of the prostaglandin f receptor
08/17/2005CN1655779A Substituted benzazoles and methods of their use as inhibitors of Raf kinase
08/17/2005CN1655778A Method for the use of pyranoindole derivatives to treat infection with hepatitis C virus
08/17/2005CN1655775A Use of 20-HETE synthesizing enzyme inhibitors as therapy for cerebral vascular disease
1 ... 476 477 478 479 480 481 482 483 484 485 486 487 488 489 490 491 492 493 494 495 496 ... 1564